Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures

Carlsmed (CARL), announced that in the Hospital Inpatient Prospective Payment Systems Final Rule for fiscal year 2026, the Centers for Medicare & Medicaid Services granted New Technology Add-On Payment reimbursement to cervical fusion procedures using the company’s aprevo personalized interbody implants. Starting October 1, 2025, through the NTAP program, cervical fusion procedures utilizing Carlsmed’s aprevo devices are eligible for additional payment from CMS and private payors. The NTAP will use unique ICD-10-PCS procedure codes and provide up to an additional $21,125 in reimbursement on top of the Medicare Severity-Diagnosis Related Groups for qualifying inpatient procedures.